Menlo Park, Calif., April 23, 2014 - Geron Corporation (GERN) will announce its financial results for the first quarter ended March 31, 2014, on Thursday, May 1, 2014, after the market close. Geron`s management will also host a conference call for analysts and investors on Thursday, May 1, 2014, at 4:30 p.m. Eastern Time to discuss the company`s first quarter results and recent events.
Participants can access the conference call live via telephone by dialing 866-578-5771 (U.S.); 617-213-8055 (international). The passcode is 69839849. If accessing the conference call by telephone, please dial in at least 10 minutes early to minimize any delay in joining the call. A live audio-only webcast is also available at http://edge.media-server.com/m/p/dwk9urc8/lan/en. The audio webcast of the conference call will be available for replay approximately one hour following the live broadcast through June 1, 2014.
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Geron Corp. via GlobeNewswire
- Company Earnings
- Investment & Company Information
- Geron Corporation